标普生物科技LOF(161127)
动态评分： 5.92分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2022-06-30 | CLDX | 塞德斯医疗 | 256.93 | 0.85% |
| 2022-06-30 | DVAX | 德纳维制药 | 256.19 | 0.85% |
| 2022-06-30 | TVTX | Travere Therapeutics Inc | 243.18 | 0.81% |
| 2022-06-30 | ACAD | 阿卡迪亚 | 242.28 | 0.8% |
| 2022-06-30 | OCGN | Ocugen Inc | 242.06 | 0.8% |
| 2022-06-30 | SAGE | Sage Therapeutics Inc | 236.18 | 0.78% |
| 2022-06-30 | KYMR | Kymera Therapeutics Inc | 227.86 | 0.76% |
| 2022-06-30 | RLAY | Relay Therapeutics Inc | 230.17 | 0.76% |
| 2022-06-30 | DNLI | Denali Therapeutics Inc | 229.93 | 0.76% |
| 2022-06-30 | TPTX | Turning Point Therapeutics Inc | 215.55 | 0.72% |
| 2022-06-30 | AGIO | Agios Pharmaceuticals Inc | 203.44 | 0.68% |
| 2022-06-30 | CTIC | CTI BioPharma Corp | 201.02 | 0.67% |
| 2022-06-30 | ENTA | Enanta Pharmaceuticals Inc | 200.5 | 0.67% |
| 2022-06-30 | TGTX | TG Therapeutics Inc | 199.96 | 0.66% |
| 2022-06-30 | INO | Inovio制药 | 194.45 | 0.65% |
| 2022-06-30 | VCEL | Vericel Corp | 194.29 | 0.65% |
| 2022-06-30 | LGND | Ligand Pharmaceuticals Inc | 192.87 | 0.64% |
| 2022-06-30 | ALLO | Allogene Therapeutics Inc | 191.32 | 0.64% |
| 2022-06-30 | PTGX | Protagonist Therapeutics Inc | 191.29 | 0.64% |
| 2022-06-30 | SANA | Sana Biotechnology Inc | 183.2 | 0.61% |
公告&资料
